Mezzion Pharma Co. Ltd   Report issue

For profit Phase 3
Founded: Seoul Korea, Republic of (2002)
Status: Left NME R&D (2022)

Organization Overview

First Clinical Trial
2014
NCT02201342
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now